about
Bile Acid diarrhea: prevalence, pathogenesis, and therapyKey discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decadesGuidance: The practical management of the gastrointestinal symptoms of pelvic radiation diseaseFarnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivoDiet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levelsMulticentre prospective survey of SeHCAT provision and practice in the UK.Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.Systematic review: the management of chronic diarrhoea due to bile acid malabsorption.Advances in understanding of bile acid diarrhea.Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR.A Multicenter Prospective Study to Investigate the Diagnostic Accuracy of the SeHCAT Test in Measuring Bile Acid Malabsorption: Research Protocol.Bowel obstruction and perforation due to a large gallstone. A case report.Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 yearsUpdate on chronic diarrhea: a run-through for the clinician.Chronic radiation enteritis and malnutrition.Recycling rate of bile acids in the enterohepatic recirculation as a major determinant of whole body 75SeHCAT retention.Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.Novel therapeutic targets and predictive markers for hepatocellular carcinoma.Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.The Farnesoid X Receptor: Good for BAD.Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.Guide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer.Systemic anti-cancer therapy-induced diarrhoea.Colestyramine slows gastric emptying of liquids and reduces appetite in healthy subjects.A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea.Late gastrointestinal effects of pelvic radiation: a nurse-led service.Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.Challenging current views on bile acid diarrhoea and malabsorption.Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.Role of bile acids in inflammatory bowel disease.Bile acids inhibit Na⁺/H⁺ exchanger and Cl⁻/HCO₃⁻ exchanger activities via cellular energy breakdown and Ca²⁺ overload in human colonic cryptsSerum concentrations of lipid-soluble vitamins in dogs with exocrine pancreatic insufficiency treated with pancreatic enzymes
P2860
Q28086845-E7BB4428-41BE-49CA-8F7E-5702D13DA15DQ28240299-F9E52B9F-BDA3-4408-A38F-71E48117DA3DQ28255314-1B79E532-9734-40BE-A6A7-5E1F111BF22EQ28296042-58A95EA7-ABE1-477D-A2C0-05C2844ED99BQ28593904-0FBD655C-A786-4D0C-A17B-9900D0526630Q30382212-53CD2935-2E0E-4443-B1FD-A08BDFDAA197Q33459719-0FCC1DE2-FC31-48F3-8E86-B00BCE9FABA8Q33460604-B9D82A8E-503C-4D7B-80CB-89EDDD39FF90Q34366988-C321B749-4CC3-4DA6-9AF6-306460D46CF3Q34408666-2523580B-E7DD-47F1-888E-CB61F144DE54Q34412381-A225AC91-A784-40EA-BB46-D00D6A1F9C2CQ35073170-00A22A30-3000-4FC7-A8E8-C7EE4A2FE190Q36582765-518521BB-D902-46A3-8F76-B2CE6031B2F8Q37156029-251B48C7-1D35-42B2-83C9-F4B4C005EA24Q37579933-57568922-D833-41BB-BE70-4AB07E68A2A9Q38035797-E0ED65DD-E9CB-430D-A0C2-ABCB2CFD919FQ38096432-29D39F2A-9198-4B10-8827-98394A68B281Q38112366-D9ABC000-8799-4E85-868A-ACB09441ED75Q38176101-A4E0083F-D37D-4E25-B47D-A4F89F4136FFQ38198859-3E74501D-9185-4DD3-AF68-7D6AFE87AB5BQ38440838-BD6BB4D1-BF10-47CF-B765-24119EF7056FQ38609169-FC462BE0-C015-4263-9950-B4FF8C791167Q39125255-8398345A-39E3-4B85-BE53-230143E61A9BQ42263341-35B502C5-7CD1-4951-ACE8-45BA76B9140DQ47631630-44E6CACC-6867-470C-97B3-FD9168C33F71Q47699256-B86FD556-E99B-4295-A33A-0BBE9CAF2537Q48419593-4C33F20A-1014-406B-B66C-009D44882C92Q50079125-A507F4A8-7FB2-4767-A478-4FE1E3F0CBB6Q50207163-AA3EC064-88CA-45DC-9549-1FD17338351BQ51318198-D0880D16-2329-4866-A617-84C04F029575Q52626566-519C4E10-952C-46BC-A6B6-1215C18ADA11Q53486551-4EEEE734-BF90-463D-AD8C-01F7D8A01F6FQ54943140-B08410A7-4B27-47C5-9BD4-66EBE5725E0EQ57107234-584ACD6E-6125-42C1-ABB9-AB2E47F8D3E0Q58716731-F2F4C38E-6801-426D-B0E7-394AA00903DA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Managing bile acid diarrhoea
@ast
Managing bile acid diarrhoea
@en
Managing bile acid diarrhoea
@nl
type
label
Managing bile acid diarrhoea
@ast
Managing bile acid diarrhoea
@en
Managing bile acid diarrhoea
@nl
prefLabel
Managing bile acid diarrhoea
@ast
Managing bile acid diarrhoea
@en
Managing bile acid diarrhoea
@nl
P2860
P3181
P356
P1476
Managing bile acid diarrhoea
@en
P2093
Sanjeev S Pattni
P2860
P304
P3181
P356
10.1177/1756283X10377126
P407
P50
P577
2010-11-01T00:00:00Z